Switching targets to avoid resistance to CAR Ts

Overcoming resistance to traditional CAR Ts with CARs against an alternative B cell target

City of Hope researchers have engineered CAR T cells directed against a new B cell target that could overcome resistance to or replace canonical CAR Ts.

The novel CAR T therapy against TNFRSF13c, which was showcased in

Read the full 365 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE